Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01592552 · ClinicalTrials.gov registry record
A Biospecimen and Clinical Data Study on Patients for Drug & Biomarker Discovery
A clinical trial, sponsored by Sanguine Biosciences.
- Completed
- Registry status
- 20
- Enrollment target
NCT01592552 is a clinical trial that has completed, run by Sanguine Biosciences. The registered enrollment target is 20 participants.
The verdict
NCT01592552 has completed, sponsored by Sanguine Biosciences.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
The purpose of this research project is to collect and store blood samples and clinical data. Researchers can then use the stored samples in future studies. Through such studies, they hope to find new ways to detect, treat, and maybe even prevent or cure health problems.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2011-11 |
| Est. Completion | 2015-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01592552
The ClinicalTrials.gov registry entry for NCT01592552 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sanguine Biosciences, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01592552 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01592552 about?
NCT01592552 is a clinical study titled "A Biospecimen and Clinical Data Study on Patients for Drug & Biomarker Discovery". The purpose of this research project is to collect and store blood samples and clinical data. Researchers can then use the stored samples in future studies. Through such studies, they hope to find new ways to detect, treat, and maybe even prevent or cure health problems.
What is the current status of trial NCT01592552?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2011-11. Estimated completion is 2015-03.
Who is sponsoring clinical trial NCT01592552?
This trial is sponsored by Sanguine Biosciences, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.